MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from february
2026 private...
$187,263K
Proceeds from exercise of
series b warrants, net...
$1,377K
Proceeds from exercise of
series b warrants, net...
$2K
Net cash provided by
financing activities
$188,642K
Net change in cash
and cash...
$171,146K
Canceled cashflow
$17,496K
Other current assets
and prepaid...
-$5,214K
Stock-based compensation
$4,466K
Accrued expenses
$4,208K
Accounts payable
$1,091K
Other liabilities
$273K
Non-cash lease expense
$151K
Depreciation
$33K
Net cash used in
operating activities
-$17,301K
Effect of exchange rate
changes on cash and cash...
-$193K
Net cash used in
investing activities
-$2K
Canceled cashflow
$15,436K
Net loss
-$32,588K
Purchases of property and
equipment
$2K
Operating lease liability
-$149K
Back
Back
Cash Flow
IMMUNIC, INC. (IMUX)
IMMUNIC, INC. (IMUX)
source: myfinsight.com